Yi Zheng to Infliximab
This is a "connection" page, showing publications Yi Zheng has written about Infliximab.
Connection Strength
0.208
-
Melanoma risk during immunomodulating treatment. Melanoma Res. 2022 12 01; 32(6):411-418.
Score: 0.208
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.